Planning a New England vacation and looking for a few beautiful scenic drives in Vermont? Want to fill your days with ...

Bluebird Bio, Inc. (NASDAQ:BLUE) shares are trading higher on Wednesday following the news that Bluebird Bio, Carlyle, and SK Capital Partners, LP, have amended their definitive agreement. Under ...

Under the terms of the amended agreement, Bluebird stockholders can elect to receive either the original offer of $3.00 per share in cash plus a contingent value right (CVR) of $6.84 per share in ...

Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital By Reuters May 14, 20257:11 AM PDTUpdated May 14, 2025 ...

Although no specific reason was given, the investment firms noted that as of the close of business Monday, they had received about 2.5 million bluebird shares. That means only about 25.6% of the ...

Bluebird Bio reviews an unsolicited $4.50 per share bid from Ayrmid after agreeing to a $3.00 per share buyout with Carlyle and SK Capital.

Bluebird said late Friday that Ayrmid made an unsolicited offer to buy the company in a cash-and-stock transaction with an upfront cash payment of $4.50 per share and a one-time contingent value ...

bluebird bio, Inc. today confirmed it has received an unsolicited non-binding written proposal from Ayrmid Ltd to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time ...

While Bluebird has been generating revenue from its FDA-approved gene therapies, it has also relied heavily on a particular financial vehicle to cover expenses, such as the manufacturing of these ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK Capital for less than $30 million, in a deal that lets the beleaguered ...

SOMERVILLE, Mass., February 21, 2025--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...